Genetic Testing (PGT/PGD) in West Bengal: A Complete Clinical Guide for Fertility Patients

Preimplantation Genetic Testing (PGT) is an umbrella term for several laboratory procedures designed to evaluate the genetic integrity of embryos created through IVF before they are transferred to the uterus. Within PGT, there are three primary categories: PGT-A (formerly PGS) tests for chromosomal aneuploidy — abnormal chromosome numbers such as trisomy 21 (Down syndrome); PGT-M (formerly PGD) tests for specific monogenic or single-gene disorders like thalassemia, sickle cell anemia, spinal muscular atrophy, or Huntington's disease; and PGT-SR tests for chromosomal structural rearrangements such as balanced translocations.

The procedure involves a highly specialised embryo biopsy, typically performed on Day 5 or Day 6 when the embryo has reached the blastocyst stage. A few trophectoderm cells — those that eventually form the placenta — are carefully removed and sent to a genetics laboratory. The remaining embryo is vitrified (frozen) while awaiting results. This freeze-all protocol is standard practice and does not compromise embryo viability. In West Bengal, where thalassemia carrier rates are notably elevated compared to the national average, PGT-M is particularly clinically relevant and often life-changing for at-risk families.

Not every IVF patient requires PGT, but for specific clinical profiles, it is strongly recommended by the HomeIVF Medical Board. The primary candidates include: women aged 35 and older where chromosomal errors in eggs increase substantially with age; couples with a history of two or more unexplained recurrent miscarriages; patients who have experienced repeated IVF implantation failures despite good-quality embryos; individuals or couples who are known carriers of chromosomal translocations; and families with a history of X-linked disorders, autosomal dominant, or autosomal recessive conditions such as cystic fibrosis, Duchenne muscular dystrophy, or beta-thalassemia.

In West Bengal, beta-thalassemia is of particular public health concern. The state has one of the highest carrier frequencies in India, with studies indicating that approximately 10-15% of some Bengali communities carry the thalassemia trait. Couples in Kolkata, Howrah, Durgapur, and across rural districts where consanguineous marriages may occur are especially encouraged to pursue carrier screening before conception and PGT-M if both partners are carriers. Additionally, couples with a family history of chromosomal disorders identified through karyotyping are strong candidates for PGT-SR. HomeIVF coordinates pre-genetic counselling sessions to help West Bengal families understand their specific risk category before proceeding.

Unlike many fertility conditions, there are no physical 'symptoms' of carrying a chromosomal abnormality or genetic mutation — which is precisely what makes PGT so important. However, there are clear clinical red flags that should prompt a couple to seek genetic assessment as part of their fertility workup.

Recurrent miscarriage is perhaps the most common and emotionally devastating indicator. If a couple has experienced two or more pregnancy losses, chromosomal abnormalities in the embryo account for approximately 50-60% of first-trimester miscarriages. Repeated IVF failures — where good-quality embryos consistently fail to implant — may suggest undetected aneuploidy. A personal or family history of a child born with a chromosomal disorder such as Down syndrome, Patau syndrome, or Edwards syndrome is another strong indicator. Similarly, a prior abnormal prenatal diagnosis (such as an amniocentesis result) in a previous pregnancy should prompt genetic counselling before the next IVF attempt.

For carriers of known genetic conditions — identified through blood-based carrier screening — PGT-M offers a path to parenthood without passing on the disorder. HomeIVF Medical Board recommends that all couples in West Bengal undergoing IVF complete a comprehensive carrier screening panel as a baseline, particularly those from ethnic or regional communities with known elevated carrier rates for haemoglobinopathies.

Understanding the procedural pathway helps couples in West Bengal make informed decisions. The PGT process is integrated within a standard IVF cycle and unfolds across several well-defined stages.

Step 1 — Genetic Counselling: Before any cycle begins, a certified genetic counsellor reviews family history, previous medical records, and indicates which type of PGT is appropriate. HomeIVF facilitates access to senior genetic counsellors through its telemedicine platform, meaning patients in Siliguri or Durgapur need not travel to Kolkata for this initial step.

Step 2 — IVF Stimulation and Egg Retrieval: The female partner undergoes ovarian stimulation followed by egg retrieval under sedation. The fertilised embryos are cultured in the laboratory to the blastocyst stage over 5-6 days.

Step 3 — Embryo Biopsy: On Day 5 or 6, an embryologist performs a laser-assisted biopsy, removing 3-5 trophectoderm cells from each viable blastocyst. This requires highly skilled embryologists and advanced equipment.

Step 4 — Genetic Analysis: Biopsied cells are sent to an accredited genetics laboratory. Depending on the test type, analysis uses Next Generation Sequencing (NGS), array CGH, or PCR-based techniques.

Step 5 — Embryo Transfer: Only euploid (chromosomally normal) embryos are selected for transfer in a subsequent frozen embryo transfer (FET) cycle. HomeIVF coordinates the entire workflow end-to-end, from biopsy coordination to result interpretation.

One of the most frequently asked questions from patients across West Bengal — from Kolkata's Salt Lake area to Howrah's clinic corridors — is what genetic testing adds to the overall cost of an IVF cycle. PGT is an add-on to a base IVF package, and the additional cost varies depending on the type of test (PGT-A versus PGT-M), the number of embryos biopsied, and the laboratory partner used.

HomeIVF offers IVF packages starting from ₹1.5 lakh, with PGT add-on costs clearly itemised during the consultation process so that families can make financially informed decisions. PGT-M for specific monogenic disorders typically costs more than PGT-A due to the need for probe design and validation specific to the family's mutation — a process that must be completed 4-8 weeks before the IVF cycle begins. This is an important timeline factor couples must plan for.

Total timeline from initial consultation to embryo transfer in a PGT cycle typically spans 3-5 months, accounting for genetic counselling, probe preparation (if PGT-M), stimulation, biopsy, genetic analysis (10-21 days), and a subsequent FET cycle. HomeIVF's digital coordination platform sends real-time updates to patients throughout this process, reducing uncertainty and improving the experience for couples managing work and family responsibilities across West Bengal.

Access to PGT in India has historically been limited to a handful of super-specialty hospitals in major metros. Patients from Siliguri near the Himalayan foothills, from Durgapur in the Bardhaman district, or from smaller towns in North 24 Parganas often had to travel repeatedly to Kolkata or even to cities like Mumbai or Delhi for genetic testing services — incurring significant cost, time, and emotional burden.

HomeIVF fundamentally changes this access equation. Through its AI-powered fertility platform, HomeIVF connects West Bengal patients with a curated network of ICMR-compliant IVF centres and accredited genetics laboratories that meet rigorous quality standards. Senior-specialist care — including genetic counselling, embryologist expertise, and reproductive endocrinology — is delivered to patients wherever they are, without compromise. Patients in Howrah can have monitoring blood draws and ultrasounds performed locally while their embryo biopsy is coordinated at a certified partner lab.

The HomeIVF Medical Board reviews each patient's genetic history and helps design a personalised testing protocol. The platform's digital case management system ensures that biopsy samples, lab reports, and FET scheduling are seamlessly coordinated, eliminating the fragmented care experience that has historically frustrated West Bengal fertility patients. Telemedicine consultations mean that language barriers — with support available in Bengali — are also addressed.

Couples in West Bengal considering PGT deserve honest, evidence-based information about what the technology can and cannot achieve. PGT-A significantly improves the probability that a transferred embryo will implant successfully and result in a live birth — primarily by eliminating aneuploid embryos that would otherwise fail to implant or result in miscarriage. Studies suggest that transferring a single euploid blastocyst results in clinical pregnancy rates of 50-65% per transfer in younger women, with rates decreasing with advancing maternal age.

However, it is essential to understand that PGT-A does not guarantee a live birth. Euploid embryos can still fail to implant due to uterine factors, endometrial receptivity issues, or other causes unrelated to chromosomal status. For PGT-M, the technology is highly accurate — typically exceeding 98% diagnostic accuracy for the specific mutation being tested — but a small risk of misdiagnosis (allele dropout) remains, which is why confirmatory prenatal testing during pregnancy is still advised.

The HomeIVF Medical Board recommends that patients with limited embryo numbers discuss the decision to biopsy carefully, since not all embryos survive the biopsy process, and low embryo yield is a factor. Overall IVF success rates in India typically range from 40-55% per cycle depending on age and underlying cause, and PGT is a tool to optimise embryo selection within that framework — not a guarantee.

Despite growing awareness, several structural barriers continue to limit access to PGT for families across West Bengal. These include: a shortage of certified genetic counsellors outside Kolkata's major hospitals; limited availability of accredited embryo biopsy facilities in Tier-2 cities like Durgapur or Siliguri; a lack of transparency around testing costs and timelines; language barriers in accessing technical fertility information in Bengali; and social stigma around discussing genetic conditions within families and communities.

HomeIVF is purpose-built to dismantle these barriers. Its technology platform aggregates accredited partner clinics across West Bengal into a single, quality-assured network. Bengali-language support ensures that patients from Howrah to the Sundarbans can access genetic counselling without language being an obstacle. The platform's transparent pricing model — with no hidden fees — addresses cost opacity. Educational content developed and reviewed by the HomeIVF Medical Board helps demystify PGT for first-generation fertility treatment seekers.

For couples who have faced the grief of recurrent miscarriage, chromosomally abnormal pregnancies, or the fear of passing on a hereditary condition, HomeIVF represents a compassionate, clinically rigorous, and geographically accessible path forward — one that brings the genetic testing expertise of India's best fertility specialists directly to West Bengal families.